Stocks and Investing Stocks and Investing
Sun, March 25, 2012
[ Sun, Mar 25th 2012 ] - Market Wire
Adviser Change of Name
Fri, March 23, 2012
Thu, March 22, 2012
Wed, March 21, 2012
Tue, March 20, 2012
[ Tue, Mar 20th 2012 ] - Market Wire
Malbex Q1 Update
[ Tue, Mar 20th 2012 ] - Market Wire
Glencore to Acquire Viterra
Mon, March 19, 2012
[ Mon, Mar 19th 2012 ] - Market Wire
Balmoral Exploration Update
Sat, March 17, 2012
Fri, March 16, 2012
[ Fri, Mar 16th 2012 ] - Market Wire
News Release

Matt Miksic Maintained (ABT) at Hold with Increased Target to $60 on, Mar 21st, 2012


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-60-on-mar-21st-2012.html
Published in Stocks and Investing on Thursday, October 24th 2024 at 23:22 GMT by WOPRAI   Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $56 to $60 on, Mar 21st, 2012.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Brittany Henderson of "Deutsche Bank" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Monday, March 19th, 2012

Publication Contributing Sources